Healthcare provider profile · identity verified

Brian Joseph Luc, M.D.

Internal Medicine · CHICAGO, IL · NPI 1376833657

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	943	288
Amlodipine Besylate	Amlodipine Besylate	601	190
Losartan Potassium	Losartan Potassium	420	119
Metformin Hcl	Metformin Hcl	334	100
Albuterol Sulfate Hfa	Albuterol Sulfate	307	111
Metoprolol Succinate	Metoprolol Succinate	278	77
Hydrochlorothiazide	Hydrochlorothiazide	261	78
Gabapentin	Gabapentin	239	67
Rosuvastatin Calcium	Rosuvastatin Calcium	224	71
Lisinopril	Lisinopril	220	66
Tamsulosin Hcl	Tamsulosin Hcl	218	71
Jardiance	Empagliflozin	195	53
Fluticasone Propionate	Fluticasone Propionate	192	91
Omeprazole	Omeprazole	175	70
Pantoprazole Sodium	Pantoprazole Sodium	161	48
Carvedilol	Carvedilol	160	38
Levothyroxine Sodium	Levothyroxine Sodium	138	36
Ozempic	Semaglutide	131	40
Furosemide	Furosemide	128	39
Enalapril Maleate	Enalapril Maleate	122	32
Spironolactone	Spironolactone	121	37
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	116	33
Nifedipine Er	Nifedipine	96	33
Metformin Hcl Er	Metformin Hcl	92	29
Chlorthalidone	Chlorthalidone	91	38
Eliquis	Apixaban	91	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	85	25
Potassium Chloride	Potassium Chloride	81	17
Glipizide	Glipizide	75	19
Duloxetine Hcl	Duloxetine Hcl	72	25
Amitriptyline Hcl	Amitriptyline Hcl	67	13
Finasteride	Finasteride	64	18
Famotidine	Famotidine	63	23
Montelukast Sodium	Montelukast Sodium	63	20
Hydralazine Hcl	Hydralazine Hcl	62	15
Simvastatin	Simvastatin	62	16
Torsemide	Torsemide	62	12
Symbicort	Budesonide/Formoterol Fumarate	61	16
Pravastatin Sodium	Pravastatin Sodium	59	25
Tramadol Hcl	Tramadol Hcl	56	16
Prednisone	Prednisone	55	29
Levetiracetam	Levetiracetam	54	11
Alendronate Sodium	Alendronate Sodium	53	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	suppressed
Rybelsus	Semaglutide	52	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	51	suppressed
Meclizine Hcl	Meclizine Hcl	51	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	13
Oxybutynin Chloride Er	Oxybutynin Chloride	49	20
Baclofen	Baclofen	48	suppressed
Pregabalin	Pregabalin	48	21
Farxiga	Dapagliflozin Propanediol	47	12
Lovastatin	Lovastatin	47	13
Trazodone Hcl	Trazodone Hcl	47	15
Clopidogrel	Clopidogrel Bisulfate	45	18
Metoprolol Tartrate	Metoprolol Tartrate	45	16
Xarelto	Rivaroxaban	45	14
Allopurinol	Allopurinol	42	12
Ibuprofen	Ibuprofen	42	21
Entresto	Sacubitril/Valsartan	41	12
Escitalopram Oxalate	Escitalopram Oxalate	40	15
Sertraline Hcl	Sertraline Hcl	38	13
Varenicline Tartrate	Varenicline Tartrate	37	15
Breo Ellipta	Fluticasone/Vilanterol	36	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	12
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	35	19
Donepezil Hcl	Donepezil Hcl	34	12
Sucralfate	Sucralfate	33	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Glimepiride	Glimepiride	28	suppressed
Naproxen	Naproxen	28	12
Trulicity	Dulaglutide	28	11
Linzess	Linaclotide	27	suppressed
Mounjaro	Tirzepatide	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Novolog Flexpen	Insulin Aspart	26	13
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Testosterone Cypionate	Testosterone Cypionate	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	12
Labetalol Hcl	Labetalol Hcl	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Atenolol	Atenolol	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Clotrimazole	Clotrimazole	19	13
Hydrocortisone	Hydrocortisone	18	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	13
Azithromycin	Azithromycin	16	13
Colchicine	Colchicine	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	12
Ciclopirox	Ciclopirox	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	14	suppressed
Brilinta	Ticagrelor	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Nitroglycerin Patch	Nitroglycerin	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Invokana	Canagliflozin	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Naratriptan Hcl	Naratriptan Hcl	12	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error